rajasekharkakarla
☆    

India,
2019-09-20 06:35

Posting: # 20628
Views: 1,076
 

 Reference replicated designs [Regulatives / Guidelines]

Dear All,

As per FDA guidelines "We recommend that if the predose value is greater than 5 percent of Cmax, you drop the subject from all BE study evaluations".

Is it applicable for fully replicated designs also, if i got greater than 5% Cmax in period 4 whether i need to exclude the subject from entire study or can we use available data for Swr calculations if subject completed two reference treatment periods.

Thanks&Regards,
Rajasekhar
Activity
 Admin contact
20,815 posts in 4,356 threads, 1,447 registered users;
online 16 (0 registered, 16 guests [including 10 identified bots]).
Forum time: 13:50 CEST (Europe/Vienna)

Repetition does not transform a lie into a truth.    Franklin D. Roosevelt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5